News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
48 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17605)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (3)
2 (126)
3 (109)
4 (46)
5 (53)
6 (70)
7 (2)
8 (3)
9 (93)
10 (97)
11 (67)
12 (115)
13 (23)
16 (45)
17 (61)
18 (207)
19 (143)
20 (33)
21 (1)
22 (1)
23 (48)
24 (107)
25 (87)
26 (242)
27 (149)
29 (6)
30 (263)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
16
17
18
19
20
21
22
23
24
25
26
27
29
30
MiMedx to Highlight Efficacy of Its Allografts in Presentations at SAWC Spring Conference
Breakfast Symposium to Underscore Statistically Significant Evidence of EpiFix® in Healing DFUs and VLUs
April 23, 2018
·
4 min read
FDA
Surmodics Announces FDA Clearance of a New .018” Low-Profile PTA Balloon Dilation Catheter
Continued progress in R&D whole-product solutions pipeline
April 23, 2018
·
4 min read
Policy
Akorn Asks Delaware Court to Require Fresenius Kabi to Fulfill Its Obligations under Merger Agreement
Akorn, Inc. (NASDAQ:AKRX), today filed a complaint in Delaware Chancery Court asking that Fresenius Kabi AG be required to fulfill its obligations under the definitive merger agreement, and issued the following statement:
April 23, 2018
·
4 min read
Business
Acurian and Synexus Launch NASH Patient Enrollment Solution
New offering introduced at second annual NASH Summit
April 23, 2018
·
4 min read
Business
EMD Serono R&D Building Earns First WELL Gold Certification™ in U.S. for New & Existing Building Project
Prestigious building distinction reflects company’s commitment to employee health and wellness
April 23, 2018
·
4 min read
Pharm Country
Elusys Receives Second Delivery Order From U.S. Government for ANTHIM®, its Treatment for Inhalation Anthrax
Elusys receives $19.7 million for delivery of ANTHIM under first Delivery Order
April 23, 2018
·
7 min read
Biotech Beach
PMDAlliance and ACADIA Pharmaceuticals Survey Reveals Serious Quality-of-Life Impact of Non-Movement Symptoms of Parkinson’s Disease
Results underscore need for greater awareness of non-movement symptoms this Parkinson’s Disease Awareness Month
April 23, 2018
·
6 min read
Business
Canon BioMedical Signs Exclusive Agreement to Distribute NEXTGENPCR Products
Canon BioMedical signs distribution agreement for the US and Canadian markets with Molecular Biology Systems
April 23, 2018
·
2 min read
Pharm Country
Ipsen Announces Efficacy and Safety Data for Dysport® (abobotulinumtoxinA) Across Multiple Therapeutic Uses at the 2018 Annual Meeting of the American Academy of Neurology
Analyses of Pooled Data of Dysport® for the Treatment of Pediatric Lower Limb Spasticity Indicate a Consistent Safety Profile
April 23, 2018
·
20 min read
Drug Development
Relapsing MS Patients Who Switched to Aubagio® (teriflunomide) Reported Increased Treatment Satisfaction in Two Clinical Studies
Patients with relapsing multiple sclerosis who switched to Sanofi Genzyme’s Aubagio® (teriflunomide) from interferon therapy experienced improvements in treatment satisfaction, according to investigational data from two clinical studies.
April 23, 2018
·
8 min read
Previous
4 of 5
Next